Self-Reported Adherence to Oral Endocrine Therapy among Breast Cancer Patients in Jordan.
作者信息
Faqeer Nour, Al Gharabli Alia, Dalbah Maha, Ammar Khawalah, Agha Randa, Shannies Hala, Sroji Hala, Al Rabie Rawaa
机构信息
Department of Pharmacy, King Hussein Cancer Center, Amman, Jordan.
Office of Scientific Affairs and Research, King Hussein Cancer Center, Amman, Jordan.
出版信息
Sultan Qaboos Univ Med J. 2022 Feb;22(1):154-156. doi: 10.18295/squmj.8.2021.096. Epub 2022 Feb 28.
Abstract
摘要
相似文献
1
Self-Reported Adherence to Oral Endocrine Therapy among Breast Cancer Patients in Jordan.
Sultan Qaboos Univ Med J. 2022 Feb;22(1):154-156. doi: 10.18295/squmj.8.2021.096. Epub 2022 Feb 28.
2
Correspondence Between Objective and Self-reported Endocrine Therapy Adherence Among Women With Breast Cancer.
Ann Behav Med. 2019 Aug 16;53(9):849-857. doi: 10.1093/abm/kay094.
3
Patient-reported Adherence to Adjuvant Aromatase Inhibitor Therapy Using the Morisky Medication Adherence Scale: An Evaluation of Predictors.
Am J Clin Oncol. 2018 May;41(5):508-512. doi: 10.1097/COC.0000000000000314.
4
Prescription refill, patient self-report and physician report in assessing adherence to oral endocrine therapy in early breast cancer patients: a retrospective cohort study in Catalonia, Spain.
Br J Cancer. 2012 Oct 9;107(8):1249-56. doi: 10.1038/bjc.2012.389. Epub 2012 Sep 6.
5
Attitudinal and social predictors of adherence to oral endocrine therapy: A psychometrically-informed model.
J Health Psychol. 2022 Mar;27(4):913-922. doi: 10.1177/1359105320982039. Epub 2020 Dec 18.
6
Association between self-report adherence measures and oestrogen suppression among breast cancer survivors on aromatase inhibitors.
Eur J Cancer. 2015 Sep;51(14):1890-6. doi: 10.1016/j.ejca.2015.06.113. Epub 2015 Jul 10.
7
Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review.
Breast Cancer Res Treat. 2018 Feb;167(3):615-633. doi: 10.1007/s10549-017-4561-5. Epub 2017 Nov 6.
8
Identifying adherence barriers to oral endocrine therapy among breast cancer survivors.
Breast Cancer Res Treat. 2019 Apr;174(2):297-305. doi: 10.1007/s10549-018-05073-z. Epub 2018 Dec 6.
9
Home medication management review in outpatients with chronic diseases in Jordan: a randomized control trial.
Int J Clin Pharm. 2016 Apr;38(2):404-13. doi: 10.1007/s11096-016-0266-9. Epub 2016 Mar 9.
10
The impact of state parity laws on copayments for and adherence to oral endocrine therapy for breast cancer.
Cancer. 2019 Feb 1;125(3):374-381. doi: 10.1002/cncr.31910. Epub 2018 Dec 19.
本文引用的文献
1
Adjuvant hormonal therapy for early breast cancer: an epidemiologic study of medication adherence.
Breast Cancer Res Treat. 2018 May;169(1):153-162. doi: 10.1007/s10549-018-4676-3. Epub 2018 Jan 23.
2
Adherence to Adjuvant Endocrine Therapy in Christchurch Women with Early Breast Cancer.
Clin Oncol (R Coll Radiol). 2018 Jan;30(1):e9-e15. doi: 10.1016/j.clon.2017.10.015. Epub 2017 Nov 2.
3
Prevalence and Determinants of Adherence to Oral Adjuvant Endocrine Therapy among Breast Cancer Patients in Singapore.
Asia Pac J Oncol Nurs. 2017 Oct-Dec;4(4):283-289. doi: 10.4103/2347-5625.212864.
4
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer.
Breast Cancer Res Treat. 2011 Apr;126(2):529-37. doi: 10.1007/s10549-010-1132-4. Epub 2010 Aug 28.
5
Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer.
Ann Oncol. 2009 Mar;20(3):431-6. doi: 10.1093/annonc/mdn646. Epub 2009 Jan 15.
Zotero 插件